977-P: Validation of the Noninvasive Blood Glucose Monitoring Device Nirlus
| العنوان: | 977-P: Validation of the Noninvasive Blood Glucose Monitoring Device Nirlus |
|---|---|
| المؤلفون: | Vera Herrmann, Anne Windjäger, Britta Wilms, Flavia Ihling, Andrej Augustinov, Sebastian M. Schmid, Svenja Meyhoefer |
| المصدر: | Diabetes. 68 |
| بيانات النشر: | American Diabetes Association, 2019. |
| سنة النشر: | 2019 |
| مصطلحات موضوعية: | Blood glucose monitoring, medicine.medical_specialty, medicine.diagnostic_test, Glucose control, business.industry, Endocrinology, Diabetes and Metabolism, Near infra red, Hypoglycemia, medicine.disease, Spouse, Diabetes mellitus, Internal medicine, Internal Medicine, medicine, In patient, Intravenous Glucose Tolerance Test, business |
| الوصف: | Background: Since the prevalence of diabetes mellitus has dramatically increased over the last decades, reliable non-invasive techniques for blood glucose monitoring are required to overcome problems and obstacles for regularly home-based blood glucose assessment. The aim of this study was the validation of the newly developed non-invasive blood glucose system NIRLUS® (Near Infra Red Light Ultra Sound, NIRLUS Engineering AG, Lübeck, Germany) under well standardized conditions. Methods: 17 healthy normal weight men (BMI: 22.4 ± 1.4 kg/m2) aged 18 to 45 years were enrolled in this study. During an intravenous glucose tolerance test (ivGTT), blood glucose profiles were measured simultaneously by two researchers with the NIRLUS® system (blinded for measured values) and a gold-standard laboratory reference system (reference, EKF-Diagnostics Biosen C-line, Barleben, Germany), respectively. During the course of ivGTT, blood glucose levels ranged from hyper- to mild hypoglycemia. Results:Correlation analysis revealed a strong association between NIRLUS and reference values (r=0.934; p Conclusion: This proof-of-concept study clearly demonstrates accuracy of blood glucose measures obtained by NIRLUS®as compared to a gold-standard laboratory reference system. Precise non-invasive glucose monitoring by NIRLUS®is feasible and might lower the burden of glucose control in patients with diabetes. Disclosure S. Meyhoefer: Research Support; Spouse/Partner; NIRLUS Engineering AG. B. Wilms: Research Support; Spouse/Partner; NIRLUS Engineering AG. F. Ihling: Research Support; Spouse/Partner; NIRLUS Engineering AG. A. Windjäger: Research Support; Spouse/Partner; NIRLUS Engineering AG. V. Herrmann: Research Support; Self; NIRLUS Engineering AG. A. Augustinov: Research Support; Self; NIRLUS Engineering AG. S.M. Schmid: Research Support; Self; NIRLUS AG. Funding NIRLUS Engineering AG |
| تدمد: | 1939-327X 0012-1797 |
| الوصول الحر: | https://explore.openaire.eu/search/publication?articleId=doi_________::b9780134567c8921d5caeb8ed01d4cc7Test https://doi.org/10.2337/db19-977-pTest |
| حقوق: | CLOSED |
| رقم الانضمام: | edsair.doi...........b9780134567c8921d5caeb8ed01d4cc7 |
| قاعدة البيانات: | OpenAIRE |
| تدمد: | 1939327X 00121797 |
|---|